Connect with us

Legal & Regulation

Marijuana Lobbyists Going Strong for Federal Cannabis Reform Thanks to Curaleaf, Surterra



Marijuana Lobbyists Going Strong for Federal Cannabis Reform Thanks to Curaleaf, Surterra

According to Marijuana Business Daily, $2 million has been spent thus far by the marijuana lobby on federal cannabis reform efforts. Half of the companies were related to marijuana. A news report by Bloomberg Government explains, “The stepped-up efforts came as more states legalized marijuana, creating a disconnect with federal law, which still classifies marijuana as an illegal substance.”

Richie Thorne, the Chief Risk Officer of Dama Financial shared in an email with the publication, “Markets do not do well in situations of uncertainty.”

The companies in the lead concerning cannabis lobbying efforts include the National Cannabis Industry Association, Canndescent, Canopy Growth, Trulieve, Marijuana Policy Project, Dama Financial, and PharmaCann. The funding ranged from $220,000 at the most, to $60,000 at the least.

Further, in a news report by The Hill, Terry Holt, the Spokesman for the National Cannabis Roundtable, an organization that lobbies pro-marijuana policy, stated concerning marijuana lobbying that, “The fastest growing industry is getting a lot of attention from the lobbying community in D.C.,” Holt said. “I think we’re going to see a lot of folks entering the space and that is just part of the momentum we need that will make big changes.”

All information is for general informational and educational purposes only. Nothing should be interpreted as legal or wellness advice.

Jane is a regular contributor who learned about the great benefits of CBD a few years ago after starting it herself. Impressed by its effects, she's interested in helping others learn about options that can be helpful for them.

Continue Reading

Ultimate CBD Guide


ultimate-cbd-products-company-guidepopular-cbd-health-benefits best-cannabidiol-guide-resources hemp guide

TimesofCBD is the most active daily CBD news publication featuring the latest cannabis industry stories and marijuana market trends. As the leader in CBD-centric content curation, we invite all readers to come for the headlines and stay for the insights. Quality is the top priority when presenting user guides, analyzing product reviews and reporting fact-checked news announcements. All information is for educational and informational purposes only. Disclaimer.

Got news? Email

Copyright © 2020 | Latest CBD News, Cannabis Guides and Marijuana Trends
Note: Always seek real additional medical advice and consultation with a professional healthcare practitioner before considering any CBD. No statements found on this website have underwent Food and Drug Administration evaluation. The efficacy of any products or claims made have never been approved by the FDA either. No products shall ever be intended to diagnose, treat or cure any disease or prevent any ailment.